找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Structure-Activity Relationships of Anti-Tumour Agents; D. N. Reinhoudt,T. A. Connors,K. W. Poll Book 1983 Martinus Nijhoff Publishers, Th

[复制链接]
楼主: audiogram
发表于 2025-3-25 06:09:46 | 显示全部楼层
https://doi.org/10.1007/978-94-009-6798-4antibiotics; cancer; chemotherapy; metabolism; research; tumor
发表于 2025-3-25 07:40:26 | 显示全部楼层
发表于 2025-3-25 13:21:54 | 显示全部楼层
发表于 2025-3-25 18:22:33 | 显示全部楼层
Book 1983of cancer, aiming to improve prognosis of the cancer patient. For almost a century, surgery has now been the main treatment modality for the cancer patient. During the past 50 years radiation therapy has developed as a second important modality of treatment. However, neither of the two modalities ar
发表于 2025-3-25 22:25:06 | 显示全部楼层
Introduction,tient. During the past 50 years radiation therapy has developed as a second important modality of treatment. However, neither of the two modalities are able to cure the majority of cancer patients, as the disease is so often metastasized at presentation.
发表于 2025-3-26 03:22:05 | 显示全部楼层
Structure-Activity Relationships among Antitumour Quinones,iamycin, mitomycin C, streptonigrin, lapachol, trenimon and carbazilquinone. New quinoid compounds currently under investigation by the National Cancer Institute (NCI) in the United States are AZQ, dihydroxyanthracenedione, aclacinomycin A and 7-OMEN.
发表于 2025-3-26 08:10:02 | 显示全部楼层
In Vitro Oxidative Activation: A Model for the Cytotoxic Action of 9-Hydroxy Ellipticine Derivativeellipticine (9-OH-E) leads to a compound, N2-methyl 9-hydroxy ellipticinium (NSC 264137) (9-OH-NME+) which is one of the most efficient anticancer drug in these series (3) and has been retained for clinical use in humans (4).
发表于 2025-3-26 09:48:43 | 显示全部楼层
DTIC: A Springboard to New Antitumour Agents, DTIC as there are chemists and biochemists who, ensnared by the apparent deceptive simplicity of the molecule, have responded to the challenge but abjectly failed in the task of unravelling its perverse secrets.
发表于 2025-3-26 15:20:11 | 显示全部楼层
发表于 2025-3-26 17:44:13 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-20 08:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表